RevOpsis Therapeutics employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.
RevOpsis Therapeutics's investors include ExSight Ventures, National Eye Institute.
RevOpsis Therapeutics is headquartered in Springfield, United States.
RevOpsis Therapeutics employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.
RevOpsis Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RevOpsis Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/revopsis-therapeutics. Accessed October 1, 2026.
VCBacked. (2025). RevOpsis Therapeutics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/revopsis-therapeutics
{{cite web |title=RevOpsis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/revopsis-therapeutics |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated